Zebularine Promotes Hepatic Differentiation of Rabbit Bone Marrow Mesenchymal Stem Cells by Interfering with p38 MAPK Signaling.

作者: Yong-Heng Luo , Juan Chen , En-Hua Xiao , Qiu-Yun Li , Yong-Mei Luo

DOI: 10.1155/2018/9612512

关键词:

摘要: Demethylating agent zebularine is reported to be capable of inducing differentiation stem cells by activation methylated genes, though its function in hepatocyte unclear. p38 signal pathway involved hepatocytes and regulating DNA methyltransferases 1 (DNMT1) expression. However, little known about the impact on bone marrow mesenchymal (BMMSCs) signaling during hepatic differentiation. The present study investigated effects rabbit BMMSCs, as well role DNMT1 differentiation, with aim developing a novel strategy for improving derivation hepatocytes. BMMSCs were treated at concentrations 10, 20, 50, 100 μM presence growth factor; changes levels hepatic-specific alpha-fetoprotein albumin detected determined RT-PCR, WB, immunofluorescence staining. Expression phosphorylated urea production ICG metabolism was also analyzed. Zebularine 50 μM could not affect cell viability after 48 h. treatment leads an inhibition DNMT activity increase proteins vitro; addition induced expression metabolism. activated simulated HGF; facilitated synthesis cells. restrained which HGF. Therefore, this demonstrated that exhibited terminal vitro association least partially participates zebularine-induced BMMSCs.

参考文章(35)
Matthias S. Roost, Roderick C. Slieker, Monika Bialecka, Liesbeth van Iperen, Maria M. Gomes Fernandes, Nannan He, H. Eka D. Suchiman, Karoly Szuhai, Françoise Carlotti, Eelco J. P. de Koning, Christine L. Mummery, Bastiaan T. Heijmans, Susana M. Chuva de Sousa Lopes, DNA methylation and transcriptional trajectories during human development and reprogramming of isogenic pluripotent stem cells Nature Communications. ,vol. 8, pp. 908- ,(2017) , 10.1038/S41467-017-01077-3
Samantha S. Dykes, Joshua J. Steffan, James A. Cardelli, Lysosome trafficking is necessary for EGF-driven invasion and is regulated by p38 MAPK and Na+/H+ exchangers BMC Cancer. ,vol. 17, pp. 672- 672 ,(2017) , 10.1186/S12885-017-3660-3
Ibrahim Mortada, Rola Mortada, Epigenetic changes in mesenchymal stem cells differentiation. European Journal of Medical Genetics. ,vol. 61, pp. 114- 118 ,(2017) , 10.1016/J.EJMG.2017.10.015
Masoumeh Fardi, Saeed Solali, Majid Farshdousti Hagh, Epigenetic mechanisms as a new approach in cancer treatment: An updated review Genes and Diseases. ,vol. 5, pp. 304- 311 ,(2018) , 10.1016/J.GENDIS.2018.06.003
Chuntao Deng, Qiuchan Deng, Wenbin Kuang, Shaowei Shu, Meirong Zhou, Wensheng Li, Hepatocyte growth factor induces breast cancer cell invasion via the PI3K/Akt and p38 MAPK signaling pathways to up-regulate the expression of COX2. American Journal of Translational Research. ,vol. 9, pp. 3816- 3826 ,(2017)
Qiliang Xi, Ning Gao, Yang Yang, Weiyuan Ye, Bo Zhang, Jun Wu, Gening Jiang, Xuejun Zhang, Anticancer drugs induce hypomethylation of the acetylcholinesterase promoter via a phosphorylated-p38-DNMT1-AChE pathway in apoptotic hepatocellular carcinoma cells. The International Journal of Biochemistry & Cell Biology. ,vol. 68, pp. 21- 32 ,(2015) , 10.1016/J.BIOCEL.2015.08.013
Yun He, Jiejie Cui, Tongchuan He, Yang Bi, None, 5-azacytidine promotes terminal differentiation of hepatic progenitor cells. Molecular Medicine Reports. ,vol. 12, pp. 2872- 2878 ,(2015) , 10.3892/MMR.2015.3772
Kristina K. Aenlle, Kevin M. Curtis, Bernard A. Roos, Guy A. Howard, Hepatocyte Growth Factor and p38 Promote Osteogenic Differentiation of Human Mesenchymal Stem Cells Molecular Endocrinology. ,vol. 28, pp. 722- 730 ,(2014) , 10.1210/ME.2013-1286
Hua Dock, Annette Theodorsson, Elvar Theodorsson, DNA Methylation Inhibitor Zebularine Confers Stroke Protection in Ischemic Rats Translational Stroke Research. ,vol. 6, pp. 296- 300 ,(2015) , 10.1007/S12975-015-0397-7